Last update:
Oncology & Cancer news
Oncology & Cancer
Engineered protein complex could help immunotherapies target hard-to-treat neuroblastoma
Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach otherwise "invisible" tumors by helping guide therapies to their appropriate targets. This could be ...
4 hours ago
0
0
Oncology & Cancer
A double-pronged attack on malignant B cells with improved immunotherapy
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that recognizes two distinct ...
4 hours ago
0
0
How major nuclear protein complexes control specialized gene regulation in cancer and beyond
Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many human diseases, including cancers. However, how molecular machines—protein complexes—that control ...
5 hours ago
0
0
Multi-pronged antibodies could boost immune response to cancer
Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.
6 hours ago
0
0
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with aggressive disease.
4 hours ago
0
0
Short-circuiting pancreatic cancer: A potential RNA therapy
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the disease. Potential treatments typically target a key mutated oncogene called KRAS. In some cases, PDAC ...
7 hours ago
0
10
Radiotracers could improve choice of bladder cancer therapies
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that can visualize tumors that carry the cell surface protein Nectin-4. This primarily occurs in the body ...
5 hours ago
0
0
Juggling two worlds: Caregivers of leukemia patients struggle to balance care and daily life
Caregivers of individuals diagnosed with acute leukemia face a difficult balancing act: meeting the urgent demands of cancer care while managing their daily responsibilities. A new qualitative study published in the journal ...
4 hours ago
0
0
Hidden blood mutations linked to higher heart disease risk after cancer treatment
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). A study by Vanderbilt Health researchers ...
10 hours ago
0
0
Walking eases fatigue among colon cancer patients
Regular physical activity—especially walking—can significantly reduce fatigue among people with colon cancer, a new study says.
13 hours ago
0
0
Liquid biopsy advances could yield new tool for detecting lung cancer mutations
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
Jan 7, 2026
0
1
Algorithm matches drugs to glioblastoma's diverse cell types, offering hope for individualized therapies
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to predict more effective treatment ...
Jan 7, 2026
0
30
Microbial patterns in colorectal tumors may predict patient survival and disease progression
A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how the disease progresses and patient outcomes. These "tissue-resident" microbes appear to play an integral ...
Jan 7, 2026
0
1
Higher intake of food preservatives linked to increased cancer risk
A higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France published in The BMJ.
Jan 7, 2026
0
15
Study links dozens of blood proteins to prostate cancer risk across populations
A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups.
Jan 7, 2026
0
1
An electronic health record-integrated AI agent advances personalized prostate cancer education
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.
Jan 7, 2026
0
0
Young cancer survivors may face faster aging and possible early-onset dementia
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to a new study, which also describes how accelerated aging occurs both at the cellular level and in brain function, ...
Jan 7, 2026
0
0
Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer, researchers discover
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. Despite initial responsiveness, ...
Jan 7, 2026
0
46
Q&A: How tumor support cells help lung cancer evade targeted therapy
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated fibroblasts, can help lung cancer cells survive targeted drug therapy by activating multiple survival ...
Jan 7, 2026
0
0
Ozempic, Wegovy might lower colon cancer risk
Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.
Jan 7, 2026
0
0
Cracking prostate cancer's code: An enzyme's central role in controlling subtypes and improving therapeutic response
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme KMT2D as a key epigenetic ...
Jan 7, 2026
0
0
A cancer 'flashlight' helps physicians determine who can benefit from targeted treatments
To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors under a spotlight.
Jan 7, 2026
0
0
Treatment developed for advanced prostate cancer that could eliminate severe side effects
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.
Jan 7, 2026
0
0
Colon cancer rates are spiking among young people: Here's why, and how to lower the risk
Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old.
Jan 7, 2026
0
0
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumor excision, surgeons often struggle to determine exactly how much tissue should be removed, ...
Jan 6, 2026
0
45
